LONDON, Oct 11 (Bernama-GLOBE NEWSWIRE) — Informa Pharma Intelligence today announces Citeline Engage, a new solution allowing contract research organizations (CROs) and sponsors to optimize site selection and increase trial efficiencies to accelerate clinical trial timelines and enable a faster path to market for drugs. Citeline Engage is a first-to-market solution designed specifically to help optimize protocol development, site feasibility, and, most importantly, increase physician engagement and drive patient awareness to support faster enrollment into clinical trials.
Clinical trials have long been a pain point for industry players, and Citeline Engage is designed to help increase efficiency across a notoriously difficult, yet imperative area, of the pharma industry. Informa Pharma Intelligence’s Citeline Engage utilizes real-world data to offer the most efficient outreach services that allow customers to better recruit investigators and patients, optimize trial protocols, and ignite awareness around trials.